A054670 logo

Daehan Nupharm Co.,Ltd. Stock Price

KOSDAQ:A054670 Community·₩93.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A054670 Share Price Performance

₩0
-7220.00 (-100.00%)
₩0
-7220.00 (-100.00%)
Price ₩0

A054670 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with acceptable track record.

3 Risks
2 Rewards

Daehan Nupharm Co.,Ltd. Key Details

₩201.6b

Revenue

₩108.1b

Cost of Revenue

₩93.5b

Gross Profit

₩82.6b

Other Expenses

₩10.9b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
775.02
46.36%
5.40%
72.5%
View Full Analysis

About A054670

Founded
1984
Employees
n/a
CEO
Wonseok Lee
WebsiteView website
www.dhnp.co.kr

Daehan Nupharm Co.,Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers pharmaceuticals drugs for cardiovascular, endocrine system, neuropsychiatric, gastrointestinal, respiratory system, antipyretic, analgesic, anti-inflammatory, anti-infective, musculoskeletal, osteoporosis, anti-cancer, urogenital system, antifungal, antiviral, hormones, dermatologic, central nervous system, anticonvulsive, amino acid, anesthetic, antiobesity, and others; vitamins; and inorganic products. The company also provides animal health and nutrition products; health supplements; and aesthetic/medical devices. The company was formerly known as Daehan New Pharm Co., Ltd and changed its name to Daehan Nupharm Co.,Ltd. in March 2025. Daehan Nupharm Co.,Ltd. was founded in 1984 and is headquartered in Hwaseong-si, South Korea.

Recent A054670 News & Updates

Solid Earnings May Not Tell The Whole Story For Daehan NupharmLtd (KOSDAQ:054670)

Nov 20
Solid Earnings May Not Tell The Whole Story For Daehan NupharmLtd (KOSDAQ:054670)

Recent updates

No updates